title: Persistent febrile illness with  multisystem organ failure associated  with clozapine.
authors.forename: D J
authors.initials: DJ
authors.lastname: Bowen
authors.forename: N L
authors.initials: NL
authors.lastname: Lucas
authors.forename: S
authors.initials: S
authors.lastname: Braude
mesh_terms: D015746:Abdominal Pain / Q000139:chemically induced; D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003951:Diagnostic Errors; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005334:Fever / Q000139:chemically induced*; D005440:Fluid Therapy; D006261:Headache / Q000139:chemically induced; D017583:Hemodiafiltration; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000139:chemically induced* / Q000628:therapy; D009638:Norepinephrine / Q000627:therapeutic use; D000069348:Quetiapine Fumarate; D012559:Schizophrenia / Q000188:drug therapy; D018746:Systemic Inflammatory Response Syndrome / Q000139:chemically induced* / Q000628:therapy; D014552:Urinary Tract Infections / Q000175:diagnosis; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D014662:Vasoconstrictor Agents; D000069348:Quetiapine Fumarate; D014635:Valproic Acid; D008094:Lithium; D003024:Clozapine; D009638:Norepinephrine